Saint Louis University

Home/Tag: Saint Louis University

NIH Funds SLU Search for New Osteoporosis Drug

Investigator Awarded $1 Million R01 Grant Sept. 30, 2015 ST. LOUIS -- David Griggs, Ph.D., director of biology at Saint Louis University’s Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to

Saint Louis University’s SLUCare Pancreatic Medicine Team Earns National Pancreas Foundation Distinction

SLU Doc Samer Alkaade Named Medical Director of Missouri NP ST. LOUIS — Saint Louis University’s SLUCare Center for Pancreatic and Biliary Diseases is one of only 30 institutions in the nation to be named a National Pancreas Foundation (NPF) Center. In addition, SLUCare physician Samer Alkaade, M.D., has been named medical director of the

Saint Louis University Enrolls First U.S. Patient in Rare Heart Disease Trial

Genetic mutation impacts an estimated 40,000 people worldwide Sept. 4, 2015 - ST. LOUIS — Earlier this year, investigators at Saint Louis University enrolled the first U.S. patient in a worldwide Phase 3 clinical trial of a medication to treat patients who have a rare form of heart failure due to a gene mutation. The

SLU Researchers Suggest Approach to Fight Common Virus in Immunosuppressed Patients

Thursday, Aug. 20, 2015 -- ST. LOUIS -- Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans. “The adenovirus can cause colds and infections in the eyes and respiratory

SLU Scientists Develop Potential New Class of Cancer Drugs in Lab

Drug Takes Aim at Cancer Metabolism, Stops Most Kinds of Cancer Carrie Bebermeyer, Medical Center Communications, Saint Louis University ST. LOUIS — In research published in Cancer Cell, Thomas Burris, Ph.D., chair of pharmacology and physiology at Saint Louis University, has, for the first time, found a way to stop cancer cell growth by targeting the Warburg

NIH Awards SLU Contract to Study Universal Flu Vaccine

Researchers Hope to Someday Say Goodbye to Yearly Shots April 27, 2015 ST. LOUIS -- Supported by a federal contract, Saint Louis University will study a concept for a universal flu vaccine that is designed to protect people from influenza pandemics that could turn deadly as well as seasonal flu caused by the influenza A

SLU Researchers Show that A3 Adenosine Receptor Can Activate “Off Signals” for Pain

Laboratory study turns off pain signal in spinal cord to provide relief from chronic pain April 16, 2015 ST.LOUIS — In a study published in the April issue of the Journal of Neuroscience, Saint Louis University scientists led by professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D., discovered that drugs targeting the A3 adenosine

Newly Enlisted T-Cell ‘Policemen’ Can Slow Down Run-Away Immune System, SLU Scientist Says

March 30, 2015 Carrie Bebermeyer, Medical Center Communications, Saint Louis University ST. LOUIS — In research published in the March issue of Immunity, Saint Louis University scientists led by Daniel Hawiger, M.D., Ph.D., assistant professor of molecular microbiology and immunology, have discovered that potentially aggressive T-cells that might lead to auto-immune disease can instead be enlisted to

SLU Scientist Aims to Improve Antibiotics to Treat Staph Infections

Yap discovers evolutionary mechanism that allows bacteria to resist antibiotics Released: 23-Jan-2015 12:00 PM EST Source Newsroom: Saint Louis University Medical Center Newswise — ST. LOUIS — In research published inProceedings of the National Academy of Sciences, assistant professor of biochemistry and molecular biology at Saint Louis University Mee-Ngan F. Yap, Ph.D., discovered new information

SLU Researcher Prevents Type I Diabetes in Lab

New approach stops destruction of beta cells, preserves insulin production Released: 20-Jan-2015 10:00 AM EST Newswise — ST. LOUIS— In new research published in Endocrinology, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports that his team has found a way to prevent type I diabetes in an animal model. Type